AGP Picks
View all

The top news stories from Europe

Provided by AGP

My European News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My European News.

Press releases published on May 6, 2026

Bioxodes presents positive final Phase 2a intracerebral hemorrhage results at ESOC affirming breakthrough potential of BIOX-101
Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th
Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update
Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease
CRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare Conference
InflaRx Announces Pricing of $150 Million Underwritten Offering of Ordinary Shares
InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases
MALLPLAZA REPORTS AN EBITDA OF USD 140.5 MILLION AND PROFITS GROW 20.5% IN THE FIRST QUARTER OF 2026
Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
Heartbot AI partners with Zyxel Networks to bring secure GenAI access to SMBs worldwide
Inriver Achieves Microsoft Certified Software Designation for Manufacturing AI, Now Available in the Microsoft Marketplace
Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026
Rhythm Pharmaceuticals Announces Participation in Upcoming Bank of America Global Healthcare Conference
Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement
UroGen Reports ZUSDURI™ Revenue More Than Doubled Quarter-over-Quarter and Provides First Quarter 2026 Financial Results and Highlights
PDS Biotech Announces Conference Call and Webcast for 2026 First Quarter Financial Results
BEYONTTRA™ (acoramidis), the First Near-Complete TTR Stabilizer (≥90%), Approved by ANVISA to Treat ATTR-CM in Brazil
Immusoft to Present Data Highlighting Positive Results from the World’s First Engineered B Cell in a Human Clinical Trial at ASGCT 2026
Altimmune to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026
Crescent Biopharma to Present at May Investor Conferences

Share us

on your social networks:

Sign up for:

My European News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.